These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17967307)

  • 1. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer.
    Yoon SM; Kim DY; Kim TH; Jung KH; Chang HJ; Koom WS; Lim SB; Choi HS; Jeong SY; Park JG
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1167-72. PubMed ID: 17967307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
    Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
    Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response.
    Kang JH; Kim YC; Kim H; Kim YW; Hur H; Kim JS; Min BS; Kim H; Lim JS; Seong J; Keum KC; Kim NK
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1018-25. PubMed ID: 19647949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
    Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
    Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer.
    Lee JH; Hyun JH; Kim DY; Yoo BC; Park JW; Kim SY; Chang HJ; Kim BC; Kim TH; Oh JH; Sohn DK
    Ann Surg Oncol; 2015 Jan; 22(1):209-15. PubMed ID: 25384698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes.
    Lee JH; Kim SH; Kim JG; Cho HM; Shim BY
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):431-8. PubMed ID: 20732756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation.
    Kim NK; Baik SH; Min BS; Pyo HR; Choi YJ; Kim H; Seong J; Keum KC; Rha SY; Chung HC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):204-10. PubMed ID: 17084555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer.
    Kim YH; Kim DY; Kim TH; Jung KH; Chang HJ; Jeong SY; Sohn DK; Choi HS; Ahn JB; Kim DH; Lim SB; Lee JS; Park JG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):761-8. PubMed ID: 15936557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
    Unsal Kilic D; Uner A; Akyurek N; Erpolat P; Dursun A; Pak Y
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):196-203. PubMed ID: 17071013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.
    Kim IJ; Lim SB; Kang HC; Chang HJ; Ahn SA; Park HW; Jang SG; Park JH; Kim DY; Jung KH; Choi HS; Jeong SY; Sohn DK; Kim DW; Park JG
    Dis Colon Rectum; 2007 Sep; 50(9):1342-53. PubMed ID: 17665260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
    Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
    Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
    Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
    Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?
    Kim DW; Kim DY; Kim TH; Jung KH; Chang HJ; Sohn DK; Lim SB; Choi HS; Jeong SY; Park JG
    Cancer; 2006 Apr; 106(8):1694-700. PubMed ID: 16532432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions).
    Wang L; Zhong XG; Peng YF; Li ZW; Gu J
    Colorectal Dis; 2014 Jan; 16(1):33-9. PubMed ID: 23848511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.